Christophe Jurczak

About

Managing Partner at Quantonation, Christophe Jurczak invests from Pre-Seed to Series B with check sizes ranging from €0.2 to €20 million, with a specialized thesis on quantum technologies. His track record and board reflect deep industry expertise: he sits on the board of PASQAL (which he co-founded), Nord Quantique, Qubit Pharmaceuticals, and memQ, covering the entire quantum value chain — from hardware (PASQAL, Nord Quantique, QphoX) to pharmaceutical applications and simulation (Qubit Pharmaceuticals, HQS Quantum Simulations). His operational background in the quantum ecosystem is extensive: co-founder and chairman of the Lab Quantique, member of the Governing Board of the European Quantum Industry Consortium (QuIC), and Associate at the Creative Destruction Lab. A PhD from École Polytechnique, he also completed the Executive Programme at ESCP Business School.

Profile

Role

Managing Partner

Fund

Quantonation

Nationality

French